[CAS NO. 1609465-88-4]  (Rac)-PF-06250112

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1609465-88-4]

Distributor
Catalog
HY-117900A
Brand
MCE
CAS
1609465-88-4

DESCRIPTION [1609465-88-4]

Overview

MDL-
Molecular Weight438.43
Molecular FormulaC22H20F2N6O2
SMILESO=C(C1=C(N)N(C2CN(C#N)CCC2)N=C1C3=CC=C(OC4=CC=C(F)C=C4F)C=C3)N

For research use only. We do not sell to patients.

Summary

(Rac)-PF-0625011 is a racemate of PF-06250112. PF-06250112 is a potent, highly selective, orally bioavailable BTK inhibitor and shows inhibitory effect toward BMX nonreceptor tyrosine kinase and TEC [1] .


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.


Solvent & Solubility

In Vitro:

DMSO : ≥ 250 mg/mL ( 570.22 mM )

* "≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.2809 mL 11.4043 mL 22.8087 mL
5 mM 0.4562 mL 2.2809 mL 4.5617 mL
10 mM 0.2281 mL 1.1404 mL 2.2809 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% Saline

    Solubility: ≥ 2.08 mg/mL (4.74 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (4.74 mM); Clear solution

* All of the co-solvents are available by MedChemExpress (MCE).